Is there a Critical Dosage and a Minimum Interval in Amiodarone-Related Optic Neuropathy?

Update Item Information
Identifier 20110208_nanos_posters_064
Title Is there a Critical Dosage and a Minimum Interval in Amiodarone-Related Optic Neuropathy?
Creator Veit Sturm; Martin Kunz; Klara Landau
Affiliation (VS) (KL) University of Zurich, Zurich, Switzerland; (MK) Herzzentrum Hirslanden, Zurich, Switzerland
Subject Amiodarone; Toxic Optic Neuropathy; Vision Loss; Visual Field Loss
Description While amiodarone-related optic neuropathy has become a well recognized entity its exact cause is still unclear. Usually, the interval between initiation of orally administered amiodarone treatment and onset of visual loss is several months.
Date 2011-02-08
Language eng
Format application/pdf
Type Text
Source 2011 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2011: Poster Presentations
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2011. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s67116x0
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 181792
Reference URL https://collections.lib.utah.edu/ark:/87278/s67116x0
Back to Search Results